98%
921
2 minutes
20
1,8-Naphthalenediol (dihydroxynaphthalene, 1,8-DHN) has been shown to be a potent hydrogen atom transfer (HAT) antioxidant compound because of the strong stabilization of the resulting free radical by intramolecular hydrogen bonding. However, the properties, reactivity, and fate of the 1,8-DHN phenoxyl radical have remained so far uncharted. Herein, we report an integrated experimental and computational characterization of the early intermediates and dimer products that arise by the oxidation of 1,8-DHN. Laser flash photolysis (LFP) studies of HAT from 1,8-DHN to the cumyloxyl and aminoxyl radicals showed the generation of a transient species absorbing at 350, 400, and >600 nm attributable to the 1,8-DHN phenoxyl radical. Peroxidase/HO oxidation of 1,8-DHN was found to proceed via an intense blue intermediate (λ 654 nm) preceding precipitation of a black melanin-like polymer. By halting the reaction in the early stages, three main dimers featuring 2,2'-, 2,4'-, and 4,4'-bondings could be isolated and characterized in pure form. Density functional theory calculations supported the generation of the 1,8-DHN phenoxyl radical and its subsequent coupling via the 2- and 4-positions giving extended quinone dimers with intense transitions in the visible range, consistent with UV-vis and LFP data. Overall, these results allowed to elucidate the mechanism of oxidative polymerization of 1,8-DHN of possible relevance to melanogenesis in fungi and other processes of environmental and astrochemical relevance.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6641764 | PMC |
http://dx.doi.org/10.1021/acsomega.8b00155 | DOI Listing |
Liver Int
September 2025
Biological Resource Center/Biobank, Fondazione "Ca Granda" IRCCS Ospedale Maggiore Policlinico, Milano, Italy.
Metabolic dysfunction associated steatohepatitis (MASH), formerly known as NASH, represents one of the leading causes of chronic liver disease worldwide. Its high prevalence is driven by insulin resistance, obesity and type 2 diabetes (T2D) and is associated with cardiovascular disease. The main driver of liver damage is fat accumulation in hepatocytes leading to inflammation and fibrosis development.
View Article and Find Full Text PDFJ Am Chem Soc
August 2025
State Key Laboratory of Green Papermaking and Resource Recycling, National Observation and Research Station of Erhai Lake Ecosystem in Yunnan, Yunnan Dali Research Institute, School of Environmental Science and Engineering, Shanghai Jiao Tong University, Shanghai 200240, P. R. China.
Organic polymerization offers a sustainable alternative for water decontamination and resource recovery; however, its popularization is bottlenecked by the unsatisfactory selectivity of traditional electron transfer processes. In this study, we demonstrate that surface high-valent iron-oxo species (≡Fe═O) on nanoscale zerovalent iron (nZVI), characterized by an unoccupied d orbital and a terminal-oxo moiety, can realize highly efficient phenol recovery via a proton-coupled electron transfer (PCET) pathway for phenol transformation into phenoxyl radicals with final polymers of 3231 g mol in average molecular weight and an impressive polymeric selectivity of 92.6%, surpassing those reported in free radical-/catalyst-oxidant complex-based systems driven by electron transfer (below 77.
View Article and Find Full Text PDFJ Phys Chem Lett
August 2025
Department of Applied Chemistry, College of Life Sciences, Ritsumeikan University, Kusatsu, Shiga 525-8577, Japan.
We report a new photochromic phenoxyl imidazolyl radical complex (PIC) that exhibits reversible homolytic C-O bond cleavage upon UV light irradiation. Ultrafast transient absorption spectroscopy revealed pronounced spectral evolution on nanosecond time scales, reflecting rotational isomerization between two open form isomers. Time-resolved infrared absorption measurements confirmed their biradical character and supported the presence of both isomers in thermodynamic equilibrium.
View Article and Find Full Text PDFKorean J Gastroenterol
July 2025
Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by progressive destruction of the intrahepatic bile ducts, potentially leading to cirrhosis and end-stage liver disease. Ursodeoxycholic acid (UDCA) has been the standard first-line therapy, but up to one-third of patients show an unsatisfactory response to UDCA, underscoring the need for novel treatments. Obeticholic acid is an approved second-line treatment targeting the farnesoid X receptor, but it is associated with adverse effects such as pruritus and the potential risk of hepatic decompensation in patients with advanced disease.
View Article and Find Full Text PDFCurr Gastroenterol Rep
July 2025
Department of Hepatology, Summit Clinical Research, San Antonio, TX, USA.
Metabolic dysfunction-associated steatohepatitis with significant fibrosis is the aggressive form of steatotic liver disease that can progress to cirrhosis and its complications. Resmetirom is a liver-directed thyroid hormone receptor beta agonist that recently received accelerated approval by the FDA based on the results of the MAESTRO trial that demonstrated reasonable safety and efficacy in achieving both MASH resolution and fibrosis regression based on histological assessment. In this review, we discuss the resmetirom clinical development program, the use of noninvasive tests to select and monitor patients for treatment, and different aspects of the utility of resmetirom in the real world.
View Article and Find Full Text PDF